Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Biogen Inc. (BIIB)

Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN 6/5/2026 10:26:20 AM

FDA Grants Breakthrough Therapy Designation To Biogen's Salanersen In Treating Muscular Atrophy 6/4/2026 11:24:10 AM

Biogen's Salanersen Wins FDA Breakthrough Therapy Designation For Spinal Muscular Atrophy Treatment 6/4/2026 7:51:14 AM

Biogen Secures FDA Breakthrough Therapy Designation For Salanersen In SMA Treatment 6/4/2026 7:34:46 AM

Biogen And UCB Present Positive PHOENYCS GO Data For DZP In Treating Lupus 6/4/2026 6:24:08 AM

Weekly Buzz: GH Wins FDA Nod; NMPA Green Lights HCM; MDT To Acquire SPR ; BIIB HALTS BIIB112 5/22/2026 10:47:39 AM

Biogen And Denali Halt Development Of BIIB122 After Phase 2b LUMA Study Misses Key Goals 5/22/2026 4:11:16 AM

Biogen And Denali Stop BIIB122 Development After Phase 2b Parkinson's Trial Shows No Benefit 5/22/2026 1:22:35 AM

Biogen : Phase 2b Study Of BIIB122 In Early-stage Parkinson's Disease Fails To Meet Main Goal 5/21/2026 8:54:57 PM

Biogen Phase 2 CELIA Study Fails To Meet Primary Endpoint, Stock Up In Pre-Market 5/14/2026 8:18:03 AM

Biogen's Diranersen Shows Cognitive Benefit In Phase 2 CELIA Study In Alzheimers Disease 5/14/2026 7:11:12 AM

Eisai, Biogen Say FDA Extends Review Of LEQEMBI IQLIK As A Starting Dose For Early AD 5/8/2026 3:11:10 AM

Eisai And Biogen Secure Three-Month FDA Review Extension For LEQEMBI; New PDUFA Date Set For August 24, 2026 5/8/2026 2:37:53 AM

Biogen Updates 2026 Guidance 4/29/2026 7:25:05 AM

Biogen Q1 GAAP EPS $2.15; Non-GAAP EPS Of $3.57 4/29/2026 7:06:01 AM

Biogen To Acquire TJ Bio's Rights To Felzartamab In The Greater China Region 4/20/2026 7:41:06 AM

Biogen Secures Global Rights To Felzartamab With TJ Biopharma Deal In Greater China 4/20/2026 7:32:44 AM

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS 4/3/2026 5:10:06 AM

Apellis Shares Surge 135% After Acquisition Agreement With Biogen 3/31/2026 10:41:56 AM

Biogen To Acquire Apellis 3/31/2026 7:21:54 AM

- 1
- 2
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap